Skip to main content
. 2023;77(6):460–464. doi: 10.5455/medarh.2023.77.460-464

Table 2. EORTC risk of bladder cancer recurrence in the chemotherapy group.

Recurrence Total
Yes No
Risk of recurrence
Chemotherapy group
Low risk N 1 20 21
% 4.8% 95.2% 100%
Intermediate risk N 4 11 15
% 26.7% 73.3% 100%
High risk N 4 11 15
% 26.7% 73.3% 100%